Clinical Trials Browser

Phase 2 × Biliary Cancer Metastatic × Gastrointestinal × Clear all

NCT07062536 2025-07-14

mFOLFOX/mFOLFIRI vs. mFOLFOX in Advanced or Recurrent Biliary Tract Cancer Second-line

Phase 2 Not yet recruiting

Gastrointestinal

Biliary Cancer Metastatic

NCT03464968 2020-12-02

mFOLFOX vs. mFOLFIRI in Advanced or Recurrent Biliary Tract Cancer Refractory to First Line

Phase 2 Completed

Gastrointestinal

Biliary Cancer Metastatic